Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2009-05-29 | Ms. Ivers-Read is and has been since April 2002, Executive Vice President, Development Operations of Pharmion Corp., a publicly held biotech company. From 1996 to 2001, she held various regulatory positions with Hoechst Marion Roussel and its successor Aventis Pharmaceuticals, Inc. |
| 2010-09-22 | Ms. Ivers-Read has a BS with Honors from University College London in Pharmacology. |
| 2011-10-25 | Ms. Ivers-Read has a BS with Honors from University College London in Pharmacology. |
| 2012-10-26 | Ms. Ivers-Read has a BS with Honors from University College London in Pharmacology. |
| 2013-10-31 | Ms. Ivers-Read has a BS with Honors from University College London in Pharmacology. |
Data sourced from SEC filings. Last updated: 2026-02-03